151 related articles for article (PubMed ID: 1611225)
1. Targeted estrogen/progesterone replacement therapy for osteoporosis: calculation of health care cost savings.
Clark AP; Schuttinga JA
Osteoporos Int; 1992 Jul; 2(4):195-200. PubMed ID: 1611225
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
Whittington R; Faulds D
Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy.
Tosteson AN; Rosenthal DI; Melton LJ; Weinstein MC
Ann Intern Med; 1990 Oct; 113(8):594-603. PubMed ID: 2119161
[TBL] [Abstract][Full Text] [Related]
4. Labor costs and economic impact of a primary care clinical pharmacy service on postfracture care in postmenopausal women.
Irwin AN; Billups SJ; Heilmann RM
Pharmacotherapy; 2015 Mar; 35(3):243-50. PubMed ID: 25809175
[TBL] [Abstract][Full Text] [Related]
5. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
6. Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.
Orwoll ES; Nelson HD
J Clin Endocrinol Metab; 1999 Jun; 84(6):1872-4. PubMed ID: 10372678
[TBL] [Abstract][Full Text] [Related]
7. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.
King AB; Saag KG; Burge RT; Pisu M; Goel N
Osteoporos Int; 2005 Dec; 16(12):1545-57. PubMed ID: 15942702
[TBL] [Abstract][Full Text] [Related]
8. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
Yoshimura M; Moriwaki K; Noto S; Takiguchi T
Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of osteoporosis with hormone replacement therapy.
Christiansen C
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
Moriwaki K; Noto S
Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
[TBL] [Abstract][Full Text] [Related]
11. Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
Ni W; Jiang Y
Osteoporos Int; 2017 Feb; 28(2):529-538. PubMed ID: 27581955
[TBL] [Abstract][Full Text] [Related]
12. Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy.
Visentin P; Ciravegna R; Fabris F
Maturitas; 1997 Apr; 26(3):185-92. PubMed ID: 9147350
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
14. A cost-effectiveness analysis of hormone replacement therapy in the menopause.
Cheung AP; Wren BG
Med J Aust; 1992 Mar; 156(5):312-6. PubMed ID: 1588862
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
[TBL] [Abstract][Full Text] [Related]
16. Perimenopausal bone density screening--will it help prevent osteoporosis?
Garton MJ; Cooper C; Reid D
Maturitas; 1997 Jan; 26(1):35-43. PubMed ID: 9032745
[TBL] [Abstract][Full Text] [Related]
17. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study.
Sullivan SD; Lehman A; Thomas F; Johnson KC; Jackson R; Wactawski-Wende J; Ko M; Chen Z; Curb JD; Howard BV
Menopause; 2015 Oct; 22(10):1035-44. PubMed ID: 25803670
[TBL] [Abstract][Full Text] [Related]
18. Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial.
Majumdar SR; Johnson JA; Lier DA; Russell AS; Hanley DA; Blitz S; Steiner IP; Maksymowych WP; Morrish DW; Holroyd BR; Rowe BH
Osteoporos Int; 2007 Mar; 18(3):261-70. PubMed ID: 17086470
[TBL] [Abstract][Full Text] [Related]
19. The cost of treating osteoporosis in a managed health care organization.
Desai SS; Duncan BS; Sloan AS
J Manag Care Pharm; 2003; 9(2):142-9. PubMed ID: 14613343
[TBL] [Abstract][Full Text] [Related]
20. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
